Pharmaceutical marketing

The new realities, future needs of marketing in the healthcare industry.

17 June 2010

From 18h30



Cercle de l'Union Interalliée


Marc-Olivier and Jean Bévierre Reboullet associated Cabinet CEPTON Strategies will present their analysis of the major changes in the environment in Europe and their vision of the new Marketing levers.

The profound changes to environmental health required to develop pharmaceutical marketing typically very focused on the prescriber to take better account of the “market access”, deepen cost / benefit analysis and use alternative channels of promotion.

The reduction of health expenditure concerns all major countries. Organisations are in place to better evaluate the cost / benefit ratio of drugs like NICE in England, Germany and IQWIG HAS.

I want to be present